Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Electric needle therapy shows promise for foot pain relief

NCT ID NCT07351331

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a technique called intratissue percutaneous electrolysis (IPE) works better than dry needling for a tight foot muscle caused by myofascial pain syndrome. Forty adults with foot pain received three treatments over 12 weeks. Researchers measured pressure on the foot and muscle activity to see which method helped more.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
intratissue percutaneous electrolysis (a minimally invasive procedure using a fine needle and low-intensity electrical current)
What this could lead to
If this works, it could offer a more effective physiotherapy option for relieving foot muscle pain and improving walking comfort in people with myofascial pain syndrome.
What could go wrong
This is a small, early-stage study with only 40 participants and no blinding, so results may not apply widely. The procedure involves needles and electrical current, which can cause discomfort or bruising.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Nov 2024

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * subjects with ages between 18 and 65 years, * hypersensitive spot within a taut band in FHB muscle. * pain upon stimulation of the MTP. * painful limit to the full range of motion Exclusion Criteria: * subjets who had bilateral LTP present. * who have had a lower limb injury or surgery within the last 6 months. * subjectss with active pathologies at the time of measurement in the lower limb. * subjectss with cognitive impairment. * subjectss with belonephobia or contraindications for the use of needles (oral anticoagulant therapy).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myofascial pain syndrome (MPS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Universidad Camilo José Cela

    Madrid, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.